Acasti Pharma, Inc. - Common Stock (ACST)
3.3700
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 20th, 9:32 PM EDT

ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the first quarter of 2025.
Via InvestorPlace · August 9, 2024

ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the fourth quarter of 2024.
Via InvestorPlace · June 21, 2024

Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities.
Via InvestorPlace · June 18, 2024

These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress.
Via InvestorPlace · May 23, 2024

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
Via Benzinga · September 26, 2023

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.
Via Benzinga · January 18, 2024

Acasti Pharma Inc (NASDAQ: ACST) shares are trading higher by 34.3% to $2.35 Tuesday morning after the company announced $7.5 million in private placement equity financing.
Via Benzinga · September 26, 2023

We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday!
Via InvestorPlace · May 9, 2023

Acasti Pharma (NASDAQ:ACST) reported its Q4 earnings results on Tuesday, June 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via Benzinga · June 21, 2022

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in DRP-selected metastatic breast cancer patients.
Via Benzinga · July 5, 2023

The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!
Via InvestorPlace · March 22, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
Via Benzinga · February 14, 2023

Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets.
Via Benzinga · January 6, 2023

The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!
Via InvestorPlace · January 6, 2023

Gainers
Via Benzinga · December 23, 2022

Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer available through SUV dealerships nationwide.
Via Benzinga · December 23, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
Via Benzinga · December 20, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022benzinga.com
Via Benzinga · December 19, 2022

Monday saw 33 companies set new 52-week lows.
Via Benzinga · November 14, 2022

Via Benzinga · December 15, 2022

On Friday, 63 stocks hit new 52-week lows.
Via Benzinga · November 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:
Via Benzinga · June 21, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via Benzinga · October 14, 2022